Walvax Biotechnology Hits Day Low of CNY 11.36 Amid Price Pressure

Walvax Biotechnology Co., Ltd. experienced a notable decline today, with the stock dropping by 3.54% and reaching an intraday low of CNY 11.36. This performance stands in contrast to the China Shanghai Composite, which fell by only 1.26% on the same day. Over the past week, Walvax has seen a more significant decrease of 5.77%, and its monthly performance reflects an 8.34% decline. The company's financial metrics indicate ongoing challenges, with net sales decreasing by 17.19% and a net profit of CNY -43.3 million, marking a substantial drop of 117.45%. Furthermore, Walvax has reported negative results for seven consecutive quarters, highlighting a trend of consistent underperformance. Over the last three years, the stock has generated a return of -70.37%, significantly lagging behind the China Shanghai Composite's 24.3% gain during the same period. With a market capitalization of CNY 18,665 million, Walvax operates within the pharmaceuticals and biotechnology sector, but its financial indicators suggest a difficult landscape ahead.